To validate the expression of CSF1R, immunohistochemical staining was performed on liver and kidney biopsy tissues obtained from healthy controls, NAFLD patients, and MN patients (Figure 6). This evidence concerns the gene CSF1R and metabolic dysfunction-associated steatotic liver disease.